Zamarin D, Burger RA, Sill MW, Powell DJ Jr, et al. Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study. J Clin Oncol 2020 Apr 10:JCO1902059. doi: 10.1200/JCO.19.02059.
PMID: 32275468